rs200918566

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_015459.5(ATL3):​c.373G>A​(p.Val125Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00181 in 1,610,208 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 5 hom. )

Consequence

ATL3
NM_015459.5 missense

Scores

4
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.11

Publications

4 publications found
Variant links:
Genes affected
ATL3 (HGNC:24526): (atlastin GTPase 3) This gene encodes a member of a family of dynamin-like, integral membrane GTPases. The encoded protein is required for the proper formation of the network of interconnected tubules of the endoplasmic reticulum. Mutations in this gene may be associated with hereditary sensory neuropathy type IF. Alternatively spliced transcript variants that encode distinct isoforms have been described. [provided by RefSeq, Feb 2014]
ATL3 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory, type 1F
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary sensory and autonomic neuropathy type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04737425).
BP6
Variant 11-63658793-C-T is Benign according to our data. Variant chr11-63658793-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 169 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATL3NM_015459.5 linkc.373G>A p.Val125Ile missense_variant Exon 3 of 13 ENST00000398868.8 NP_056274.3 Q6DD88

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATL3ENST00000398868.8 linkc.373G>A p.Val125Ile missense_variant Exon 3 of 13 1 NM_015459.5 ENSP00000381844.3 Q6DD88

Frequencies

GnomAD3 genomes
AF:
0.00111
AC:
169
AN:
152182
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00193
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000737
AC:
181
AN:
245728
AF XY:
0.000713
show subpopulations
Gnomad AFR exome
AF:
0.000326
Gnomad AMR exome
AF:
0.0000297
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00135
Gnomad NFE exome
AF:
0.00127
Gnomad OTH exome
AF:
0.000500
GnomAD4 exome
AF:
0.00188
AC:
2743
AN:
1457908
Hom.:
5
Cov.:
31
AF XY:
0.00179
AC XY:
1297
AN XY:
724962
show subpopulations
African (AFR)
AF:
0.000240
AC:
8
AN:
33316
American (AMR)
AF:
0.000137
AC:
6
AN:
43926
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39570
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84890
European-Finnish (FIN)
AF:
0.00103
AC:
55
AN:
53312
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00219
AC:
2432
AN:
1110840
Other (OTH)
AF:
0.00402
AC:
242
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
130
261
391
522
652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00111
AC:
169
AN:
152300
Hom.:
1
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41564
American (AMR)
AF:
0.000719
AC:
11
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00193
AC:
131
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
2
Bravo
AF:
0.00111
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00147
AC:
12
ExAC
AF:
0.000786
AC:
95

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuropathy, hereditary sensory, type 1F Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 30, 2021
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATL3: BP4, BS1, BS2 -

ATL3-related disorder Benign:1
May 20, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T;.
Eigen
Benign
0.065
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Benign
0.0095
T
MetaRNN
Benign
0.047
T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
6.1
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.75
N;N
REVEL
Benign
0.16
Sift
Benign
0.28
T;T
Sift4G
Benign
0.54
T;T
Polyphen
0.010
B;.
Vest4
0.25
MVP
0.67
MPC
0.30
ClinPred
0.025
T
GERP RS
4.9
Varity_R
0.29
gMVP
0.26
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200918566; hg19: chr11-63426265; API